selected scholarly activity
-
conferences
- OUTCOMES OF PARTIAL NEPHRECTOMY FOR NON-METASTATIC CT2 RENAL TUMORS: RESULTS FROM A CANADIAN MULTI-INSTITUTIONAL COLLABORATIVE. Journal of Urology. E166-E166. 2023
- OUTCOMES OF PARTIAL NEPHRECTOMY FOR NON-METASTATIC CT2 RENAL TUMORS: RESULTS FROM A CANADIAN MULTI-INSTITUTIONAL COLLABORATIVE. Journal of Urology. E394-E394. 2022
- PD3-11 CAN IT WAIT? – A SYSTEMATIC REVIEW OF IMMEDIATE VERSUS DELAYED SURGICAL REPAIR OF PENILE FRACTURE. Investigative Urology. E23-E24. 2014
- Positive surgical margins after partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer Information System database.. Journal of Clinical Oncology. 420-420. 2014
-
journal articles
- Adjuvant pembrolizumab following kidney cancer surgery A novel patient decision aid to facilitate shared decision-making. Journal of the Canadian Urological Association. 19:205-207. 2025
- Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study.. Clinical Genitourinary Cancer. 23:102342. 2025
- Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?. BJU International. 135:818-827. 2025
- MP02-05 MULTI-INSTITUTIONAL VALIDATION STUDY OF THE KIDNEY CANCER RISK EQUATION (KCRE): RESULTS FROM THE CANADIAN KIDNEY CANCER INFORMATION SYSTEM (CKCis). Investigative Urology. 213:e13. 2025
- MP02-06 DOES RADICAL NEPHRECTOMY FOR HIGH-GRADE RENAL CELL CARCINOMA IMPROVE OUTCOMES COMPARED TO PARTIAL NEPHRECTOMY? RESULTS FROM a CANADIAN MULTICENTRE COHORT. Investigative Urology. 213:e13. 2025
- MP14-16 UPFRONT CYTOREDUCTIVE NEPHRECTOMY WITH DEFERRED SYSTEMIC THERAPY FOR METASTATIC RENAL CELL CARCINOMA. Investigative Urology. 213:e492. 2025
- Evaluating Long-Term Oncologic Outcomes of Radiofrequency Ablation for T1a Renal Cell Carcinoma with Minimum 10 Years of Follow-Up.. Journal of Endourology. 2025
- Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer-Specific Mortality, and All-Cause Mortality.. Investigative Urology. 213:455-466. 2025
- A Randomized Trial of Stereotactic Body Radiation Therapy vs Radiofrequency Ablation for the Treatment of Small Renal Masses: A Feasibility Study (RADSTER).. Urology. 200:S0090-4295(25)00217-1. 2025
- Bone metastases and use of bone protective agents (BPA) for metastatic renal cell carcinoma (mRCC): A contemporary national real-world analysis.. Journal of Clinical Oncology. 43. 2025
- Radiographic predictors of muscle-invasive upper tract urothelial cancer. Journal of the Canadian Urological Association. 18:413-418. 2024
- The Safety and Feasibility of Ambulatory Minimally Invasive Partial Nephrectomy: A Systematic Review and Meta-Analysis.. Journal of Endourology. 38:1112-1120. 2024
- Point-of-care-ultrasound for the assessment of post-renal transplant recipients. Journal of the Canadian Urological Association. 18:110-114. 2024
- Management, outcomes and predictors of recurrence in chromophobe renal cell carcinoma: Results from the Canadian Kidney Cancer information system (CKCis).. Journal of Clinical Oncology. 42:389-389. 2024
- Real-world treatment outcomes in patients with advanced renal cell carcinoma who receive axitinib plus pembrolizumab in the first-line setting in Canadian cancer centers.. Journal of Clinical Oncology. 42:382-382. 2024
- The impact of robotic surgery access on the management of patients with clinical stage I kidney tumors at Canadian academic centers. Journal of the Canadian Urological Association. 18:55-60. 2024
- PD07-10 OUTCOMES OF PARTIAL NEPHRECTOMY FOR NON-METASTATIC cT2 RENAL TUMORS: RESULTS FROM A CANADIAN MULTI-INSTITUTIONAL COLLABORATIVE. Investigative Urology. 209:e166. 2023
- Outcomes of partial nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian multi-institutional collaborative.. Journal of Clinical Oncology. 41:690-690. 2023
- The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis.. Investigative Urology. 208:846-854. 2022
- MP24-05 OUTCOMES OF PARTIAL NEPHRECTOMY FOR NON-METASTATIC cT2 RENAL TUMORS: RESULTS FROM A CANADIAN MULTI-INSTITUTIONAL COLLABORATIVE. Investigative Urology. 207:e394. 2022
- Are there predictors of flexible ureteroscopic aptitude among novice trainees? objective assessment using simulation-based trainer.. World Journal of Urology. 40:823-829. 2022
- Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative. Urologic Oncology: Seminars and Original Investigations. 39:836.e19-836.e27. 2021
- The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis.. Investigative Urology. 206:1204-1211. 2021
- Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system. Journal of the Canadian Urological Association. 15:132-137. 2021
- Case report: Xanthogranulomatous pyelonephritis masquerading as cystic renal cell carcinoma.. British Journal of Biomedical Science. 77:87-90. 2020
- The relationship between socioeconomic status and treatment for prostate cancer in a universal healthcare system: A population-based analysis.. Journal of Clinical Oncology. 38:361-361. 2020
- Assessing gender trends in Canadian urology.. Journal of the Canadian Urological Association. 13:E393-E397. 2019
- Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer. Journal of the Canadian Urological Association. 13:404-405. 2019
- Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of renal mass biopsy in the management of kidney cancer. Journal of the Canadian Urological Association. 13:377-383. 2019
- MP42-07 ONCOLOGICAL OUTCOMES OF PATIENTS WITH SPORADIC, NON-METASTATIC RENAL CELL CARCINOMA WITH RENAL VEIN OR INFERIOR VENA CAVA TUMOR THROMBUS. Investigative Urology. 201. 2019
- Case: Spontaneous regression of post-radical prostatectomy prostate-specific antigen elevation without adjuvant therapy in a patient with lymph node metastasis. Journal of the Canadian Urological Association. 11:E315-7. 2017
- Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative. Journal of the Canadian Urological Association. 11:182-182. 2017
- Bladder Training Video versus Standard Urotherapy for Bladder and Bowel Dysfunction: A Noninferiority Randomized, Controlled Trial. Investigative Urology. 197:877-884. 2017
- Can it wait? A systematic review of immediate vs. delayed surgical repair of penile fractures. Journal of the Canadian Urological Association. 11:53-53. 2017
- Emphysematous pyelonephritis in failed renal allograft:Case report and review of literature. Urology Annals. 8:111-111. 2016
- Misuse of ultrasound for palpable undescended testis by primary care providers: A prospective study. Journal of the Canadian Urological Association. 9:387-387. 2015
- Laparoscopic nephrectomy for massive polycystic kidney disease: Updated technique and outcomes. Journal of the Canadian Urological Association. 8:341-341. 2014
- Laparoscopic Management of Advanced Renal Cell Carcinoma With Renal Vein and Inferior Vena Cava Thrombus. Urology. 83:812-817. 2014
- MP59-16 RENAL ARTERY PSEUDOANEURYSMS AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA: INCIDENCE, MANAGEMENT AND FUNCTIONAL OUTCOMES FROM CANADIAN KIDNEY CANCER INFORMATION SYSTEM DATABASE.. Investigative Urology. 191:e656. 2014
- PD17-11 POSITIVE SURGICAL MARGINS AFTER PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: PREDICTORS AND IMPACT ON ONCOLOGICAL OUTCOMES. Investigative Urology. 191:e545. 2014
- Comparison of laparoscopic donor nephrectomy with open donor nephrectomy: McMaster University experience and operative technique. Indian Journal of Transplantation. 5:191-194. 2011
-
other
- Images - pT3a clear-cell renal cell carcinoma in a renal allograft managed effectively with open partial nephrectomy.. Journal of the Canadian Urological Association. E385-E386. 2019